Bulletin
Investor Alert

New York Markets Open in:

June 17, 2020, 7:32 a.m. EDT

Worldwide Cellular Pathology Market to Expand On the Back of Increasing Prevalence Of Chronic Diseases

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Thermo Fisher Scientific Inc. (TMO)
  • X
    Danaher Corp. (DHR)
  • X
    Bio-Rad Laboratories Inc. Cl A (BIO)

or Cancel Already have a watchlist? Log In

Jun 17, 2020 (AmericaNewsHour) -- Research Nester released a report titled "Cellular Pathology Market: Global Demand Analysis & Opportunity Outlook 2028" which delivers a detailed overview of the global cellular pathology market in terms of market segmentation by application, product type, test type, technique type, end-user, instruments type, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis, and Porter’s five force model.

Cellular pathology , also known as physiologic or anatomical pathology, is a branch of science which helps with the examination of bodies and providing with apt diagnosis in relatively less time in the most inexpensive way. Cellular pathology is also used in performing the autopsy, which is an examination of the dead person’s body. The cellular pathology market is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028. In the product type, it is further segmented into consumables, probes, antibodies, and kits. In the product segment the kits, are to experience a significant growth owing to the fact of their easy availability, and ease of usage. By application type, Disease diagnosis is anticipated to be at growing state owing to in today's scenario the graph for diseases is on the rise and hence infections are also increasing thus a diagnostic method is needed for diagnosis. The high demand for histopathological diagnosis is owing to the increase in the number of cancer patients.

"The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market)."

Download/Request Sample Copy of Strategic Report:  https://www.researchnester.com/sample-request-1111

Based on the regional analysis, the cellular pathology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market for cellular pathology in North America is predicted to hold the leading share in the market on account of the presence of leading market players in the region.

Upwelling Demand For Pathological Service Resulting From High Number Of Cancer Patients

There is considerable potential of the cellular pathology market in developing countries as well as in developed countries. In developed countries this is owing to a rise in the aging population and an increase in the number of patients suffering from chronic diseases, thus there is significant potential to expand cellular pathology market. Increased investment in diagnostic testing by non-profit and governmental organizations, as well as market access for certified players in the field has led to the expansion cellular pathology market. An increasing share of international players in the market is contributing to the better availability of modern and innovative use materials and anatomical pathology tools.

"The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market)."

Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-1111

This report also provides the existing competitive scenario of some of the key players of the global cellular pathology market which includes company profiling of cellular pathology are the other key players operating in this market, such as CellPath Ltd., Gilson Incorporated, Merck KGaA (etr:MRK), Source BioScience, Thermo Fisher Scientific Inc. /zigman2/quotes/201150432/composite TMO -1.01% , Danaher Corporation /zigman2/quotes/210555154/composite DHR -1.63% , F. Hoffmann-La Roche Ltd. (swx:RO), Bio-Rad Laboratories, Inc. /zigman2/quotes/207953537/composite BIO -3.28% , and Abbott Laboratories /zigman2/quotes/203724446/composite ABT -1.18% . The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the cellular pathology market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Browse Complete Summary of this report @ https://www.researchnester.com/reports/cellular-pathology-market/1111

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates, and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds.

Contact for more Info:

AJ Daniel

Email: sales@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

The post Worldwide Cellular Pathology Market to Expand On the Back of Increasing Prevalence Of Chronic Diseases appeared first on America News Hour .

COMTEX_367009681/2606/2020-06-17T07:32:21

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/201150432/composite
US : U.S.: NYSE
$ 410.16
-4.17 -1.01%
Volume: 1.21M
Aug. 10, 2020 4:00p
P/E Ratio
44.35
Dividend Yield
0.21%
Market Cap
$163.90 billion
Rev. per Employee
$347,971
loading...
/zigman2/quotes/210555154/composite
US : U.S.: NYSE
$ 202.05
-3.35 -1.63%
Volume: 2.16M
Aug. 10, 2020 4:03p
P/E Ratio
49.84
Dividend Yield
0.36%
Market Cap
$145.71 billion
Rev. per Employee
$280,183
loading...
/zigman2/quotes/207953537/composite
US : U.S.: NYSE
$ 506.95
-17.18 -3.28%
Volume: 167,067
Aug. 10, 2020 4:03p
P/E Ratio
7.86
Dividend Yield
N/A
Market Cap
$15.55 billion
Rev. per Employee
$280,995
loading...
/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 100.04
-1.19 -1.18%
Volume: 2.78M
Aug. 10, 2020 4:02p
P/E Ratio
57.66
Dividend Yield
1.44%
Market Cap
$179.23 billion
Rev. per Employee
$296,874
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.